RECEPTOR ACTIVATOR OF NF-KB (RANK) EXPRESSION ASSOCIATES WITH BONE METASTASIS IN BREAST CARCINOMAS

被引：0
|
作者：
Santini, D.
Vincenzi, B.
Russo, A. [1 ]
Ortega, C. [2 ]
Porta, C. [6 ]
Galluzzo, S.
La Verde, N. [3 ]
Caroti, C. [4 ]
Addeo, R. [5 ]
Tonini, G.
机构：
[1] Univ Palermo, Palermo, Italy
[2] IRCC, Univ Div Med Oncol & Haematol, Turin, Italy
[3] Fatebenefratelli Oftalm Hosp, Milan, Italy
[4] EO Ospedali Galliera, Genoa, Italy
[5] S Giovanni Dio Hosp, Naples, Italy
[6] San Matteo Univ Hosp, IRCCS, Pavia, Italy
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
101P
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [21] The transcription factor NF-kB plays a critical role in IGF-promoted bone metastasis of breast cancer
    Hiraga, T
    Myoui, A
    Williams, PJ
    Mundy, GR
    Yoneda, T
    BONE, 2001, 28 (05) : S81 - S81
  • [22] NF-kB signaling regulates expression of the neonatal Fc receptor for IgG
    Liu, XD
    Ye, LL
    Kadavil, K
    Zhu, XP
    FASEB JOURNAL, 2005, 19 (04): : A325 - A325
  • [23] Therapeutic efficacy of soluble receptor activator of NF-kB (RANK) delivered by non viral gene transfer in a mouse model of osteolytic osteosarcoma
    Lamoureux, Francois
    Picarda, Gaelle
    Rousseau, Julie
    Gourden, Clothilde
    Battaglia, Severine
    Charrier, Celine
    Pitard, Bruno
    Heymann, Dominique
    Redini, Francoise
    BONE, 2008, 42 : S100 - S101
  • [24] High receptor activator of Nuclear Factor Kappa β (RANK) expression and luminal A subtype are associated with bone metastasis in patients with breast cancer
    Santhiadi, Nyoman Gde Trizka
    Sudarsa, I. Wayan
    Mahadewa, Tjokorda Gde Bagus
    BALI MEDICAL JOURNAL, 2019, 8 (03) : S537 - S541
  • [25] Prognostic importance of NF-kB in breast cancer
    Molek, K. Rajkovic
    Mustac, E.
    Hadzisejdic, I.
    Jonjic, N.
    VIRCHOWS ARCHIV, 2015, 467 : S61 - S61
  • [26] RANKL/RANK/NF-kB signaling regulates chondrogenesis.
    Xing, L
    Yamashita, T
    Childs, L
    Schwarz, EM
    O'Keefe, RJ
    Dougall, WC
    Boyce, BF
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S161 - S161
  • [27] CPAP is a Novel Transcriptional Co-activator of NF-kB
    Hung, L.
    Yang, S.
    Chang, K.
    Yen, C.
    Lin, Y.
    Chang-Liao, P.
    Tsou, J.
    Hung, W.
    Tang, T.
    Liu, Y.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 114 - 114
  • [28] NF-kB expression in IgA nephropathy outcome
    Silva, G. E. B.
    Costa, R. S.
    Ravinal, R. C.
    Ramalho, L. Z.
    dos Reis, M. A.
    Coimbra, T. M.
    Dantas, M.
    DISEASE MARKERS, 2011, 31 (01) : 9 - 15
  • [29] Validity of Osteoprotegerin and Receptor Activator of NF-κB Ligand for the Detection of Bone Metastasis in Breast Cancer
    Elfar, Gamal A.
    Ebrahim, Mohamed A.
    Elsherbiny, Nehal M.
    Eissa, Laila A.
    ONCOLOGY RESEARCH, 2017, 25 (04) : 641 - 650
  • [30] Expression of receptor activator of NF-kb (RANK), rank ligand (RANKL), and osteoprotegerin (opg) in temporal artery lesions from patients with giant-cell arteritis (GCA).: Correlation between RANKL expression, neovascularization and intimal hyperplasia
    Garcia-Martinez, A.
    Segarra, M.
    Lozano, E.
    Sanchez, M.
    Espigol, G.
    Hernandez-Rodriguez, J.
    Cid, M. C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (01) : S106 - S106
12345